ARWR (STOCKS)
Arrowhead Research Corporation
$85.590000
-1.660000 (-1.90%)
Prev close: $87.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Christopher Richard Anzalone
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12,268.57M
- Employees
- 609
- P/E (TTM)
- -38.16
- P/B (TTM)
- 26.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q3)
|
$-1.36 | $-1.35 | -0.0136 | -1.01% |
|
Mar 2026 (Q2)
|
$-0.93 | $-1.21 | +0.2810 | +23.20% |
|
Dec 2025 (Q1)
|
$0.22 | $0.26 | -0.0381 | -14.76% |
|
Sep 2025 (Q4)
|
$-0.18 | $-0.25 | +0.0656 | +26.71% |
Financial Statements
| Revenues | $669.50M |
| Benefits Costs and Expenses | $921.58M |
| Costs And Expenses | $921.58M |
| Nonoperating Income/Loss | -$25.64M |
| Operating Expenses | $895.93M |
| Depreciation and Amortization | $25.80M |
| Research and Development | $723.37M |
| Operating Income/Loss | -$226.44M |
| Income/Loss From Continuing Operations After Tax | -$272.13M |
| Income/Loss From Continuing Operations Before Tax | -$252.08M |
| Income Tax Expense/Benefit | $20.05M |
| Net Income/Loss | -$272.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | $47.83M |
| Net Income/Loss Attributable To Parent | -$319.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$327.36M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.28 |
| Diluted Earnings Per Share | -$2.28 |
| Basic Average Shares | 142,704,000 |
| Diluted Average Shares | 141,737,000 |
| Assets | $2.11B |
| Current Assets | $1.67B |
| Accounts Receivable | $15.26M |
| Prepaid Expenses | $25.37M |
| Other Current Assets | $1.63B |
| Noncurrent Assets | $440.60M |
| Fixed Assets | $373.30M |
| Other Non-current Assets | $67.30M |
| Liabilities | $1.65B |
| Current Liabilities | $283.35M |
| Accounts Payable | $27.78M |
| Wages | $23.46M |
| Other Current Liabilities | $232.12M |
| Noncurrent Liabilities | $1.36B |
| Equity | $466.04M |
| Equity Attributable To Noncontrolling Interest | $512.00K |
| Equity Attributable To Parent | $465.53M |
| Liabilities And Equity | $2.11B |
| Net Cash Flow From Operating Activities | -$59.06M |
| Net Cash Flow From Operating Activities, Continuing | -$59.06M |
| Net Cash Flow From Investing Activities | -$801.72M |
| Net Cash Flow From Investing Activities, Continuing | -$801.72M |
| Net Cash Flow From Financing Activities | $784.19M |
| Net Cash Flow From Financing Activities, Continuing | $784.19M |
| Net Cash Flow | -$76.99M |
| Net Cash Flow, Continuing | -$76.59M |
| Comprehensive Income/Loss | -$278.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $48.45M |
| Comprehensive Income/Loss Attributable To Parent | -$329.77M |
| Other Comprehensive Income/Loss | -$6.63M |